Diabetes, Weight problems, COVID-19, Insulin, and Different Antidiabetes Medicine


This article was originally published here

Diabetes treatment. 07/08/2021: dci210003. doi: 10.2337 / dci21-0003. Online before printing.


Coronavirus disease 2019 (COVID-19) viral infection, like other infections, triggers an inflammatory response that is usually confined to the airways. However, there is evidence that in a full-blown case almost all systems in the body can be affected. In addition, there is the syndrome of the cytokine storm, characterized by severe systemic inflammation and a massive release of proinflammatory cytokines (1). It is well known that obesity and diabetes are major risk factors for COVID-19 infections and that the morbidity and mortality associated with these diseases is significantly increased. Since both obesity and diabetes are linked to chronic inflammation, it is likely that the inflammatory response to COVID-19 in such patients is influenced by the background of chronic inflammation. The aim of this overview is to elucidate some of these processes and possible strategies for combating them.

PMID: 34244331 | DOI: 10.2337 / dci21-0003